February 15, 2019
FDA Panel Recommends Approval of Ketamine for Depression
A new drug developed by Johnson & Johnson named Esketamine may become the first new treatment in years for depression. An expert panel composed of psychiatrists and consumer representatives was nearly unanimous in recommending that the FDA approve a nasal spray that delivers the active ingredient ketamine. (more…)
Read More
